Payment overview · 2025
General Payments
$192,753.53
199 reported records · 15 companies
Healthcare provider profile · identity verified
Ameer Elsayed Hassan, DO
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Vascular Neurology · HARLINGEN, TX · NPI 1790941052
Verified facts
What the public records show
CMS Open Payments records show Ameer Elsayed Hassan, DO received $192,753.53 in general payments during 2025 across 199 reported records.
Medtronic, Inc. accounted for 44.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 41 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$85,003.18 | 44.1% | 70 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $40,692.63 | 21.1% | 51 | 2025 |
| Medical Device Business Services, Inc. | Unresolved — no canonical attribution shown | $29,671.83 | 15.4% | 13 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $11,208.29 | 5.8% | 16 | 2025 |
| MicroVention, Inc. | Unresolved — no canonical attribution shown | $6,462.10 | 3.4% | 6 | 2025 |
| ASAHI INTECC CO., LTD. | Unresolved — no canonical attribution shown | $5,295.00 | 2.8% | 2 | 2025 |
| Perfuze Limited | Unresolved — no canonical attribution shown | $5,000.00 | 2.6% | 1 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $2,906.75 | 1.5% | 14 | 2025 |
| Vesalio, Inc. | Unresolved — no canonical attribution shown | $2,750.00 | 1.4% | 1 | 2025 |
| Route 92 Medical, Inc. | Unresolved — no canonical attribution shown | $2,166.00 | 1.1% | 3 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $924.11 | 0.5% | 15 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $390.77 | 0.2% | 4 | 2025 |
| GE HEALTHCARE | Unresolved — no canonical attribution shown | $117.43 | 0.1% | 1 | 2025 |
| ASAHI INTECC USA, INC. | Unresolved — no canonical attribution shown | $96.17 | 0.1% | 1 | 2025 |
| Perfuze Inc | Unresolved — no canonical attribution shown | $69.27 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $124,425.00 | 24 |
| Travel and Lodging | $49,585.11 | 55 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,595.00 | 4 |
| Food and Beverage | $7,148.42 | 116 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EMBOGUARD Normalized: emboguard |
Device | DePuy Synthes Sales Inc., Medical Device Business Services, Inc. | $20,858.14 | 6 | 2025 |
Source payment records
|
|||||
| PIPELINE Normalized: pipeline |
Device | Medtronic, Inc. | $19,212.04 | 30 | 2025 |
Source payment records
|
|||||
| CORE Normalized: core |
Device | Stryker Corporation | $18,600.00 | 1 | 2025 |
Source payment records
|
|||||
| NA Normalized: na |
Device | Stryker Corporation | $18,600.00 | 1 | 2025 |
Source payment records
|
|||||
| TREVO Normalized: trevo |
Device | Stryker Corporation | $11,608.27 | 2 | 2025 |
Source payment records
|
|||||
| ASAHI Neurovascular Guide Wire Normalized: asahi neurovascular guide wire |
Device | ASAHI INTECC CO., LTD. | $5,295.00 | 2 | 2025 |
Source payment records
|
|||||
| SURPASS EVOLVE Normalized: surpass evolve |
Device | Stryker Corporation | $5,010.90 | 19 | 2025 |
Source payment records
|
|||||
| Raptor Aspiration Catheter Normalized: raptor aspiration catheter |
Device | Balt USA, LLC | $3,047.25 | 4 | 2025 |
Source payment records
|
|||||
| Stellar Guide Catheter Normalized: stellar guide catheter |
Device | Balt USA, LLC | $2,800.00 | 2 | 2025 |
Source payment records
|
|||||
| ZOOM 88-T LARGE DISTAL PLATFORM Normalized: zoom 88 t large distal platform |
Device | Imperative Care, Inc | $2,545.86 | 7 | 2025 |
Source payment records
|
|||||
| Carrier Delivery Catheter Normalized: carrier delivery catheter |
Device | Balt USA, LLC | $2,461.08 | 5 | 2025 |
Source payment records
|
|||||
| Ballast 088 Long Sheath Normalized: ballast 088 long sheath |
Device | Balt USA, LLC | $2,100.00 | 2 | 2025 |
Source payment records
|
|||||
| Optima Coil System Normalized: optima coil system |
Device | Balt USA, LLC | $1,747.21 | 8 | 2025 |
Source payment records
|
|||||
| GLIDEWIRE Normalized: glidewire |
Device | MicroVention, Inc. | $1,400.00 | 1 | 2025 |
Source payment records
|
|||||
| TARGET Normalized: target |
Device | Stryker Corporation | $1,200.00 | 1 | 2025 |
Source payment records
|
|||||
| Prestige Coil System Normalized: prestige coil system |
Device | Balt USA, LLC | $1,121.76 | 3 | 2025 |
Source payment records
|
|||||
| ONYX 18 Normalized: onyx 18 |
Device | Medtronic, Inc. | $922.98 | 3 | 2025 |
Source payment records
|
|||||
| CEREBASE Normalized: cerebase |
Device | DePuy Synthes Sales Inc. | $560.42 | 7 | 2025 |
Source payment records
|
|||||
| CEREPAK UNIFORM Normalized: cerepak uniform |
Device | DePuy Synthes Sales Inc. | $361.44 | 6 | 2025 |
Source payment records
|
|||||
| ZOOM REPERFUSION CATHETER Normalized: zoom reperfusion catheter |
Device | Imperative Care, Inc | $360.89 | 7 | 2025 |
Source payment records
|
|||||
| BROADWAY 8 Normalized: broadway 8 |
Device | Stryker Corporation | $326.82 | 4 | 2025 |
Source payment records
|
|||||
| EMBOTRAP Normalized: embotrap |
Device | DePuy Synthes Sales Inc., Medical Device Business Services, Inc. | $316.80 | 5 | 2025 |
Source payment records
|
|||||
| MO.MA ULTRA Normalized: mo ma ultra |
Device | Medtronic, Inc. | $285.44 | 3 | 2025 |
Source payment records
|
|||||
| AXIUM PRIMETM Normalized: axium primetm |
Device | Medtronic, Inc. | $208.90 | 3 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $191.75 | 2 | 2025 |
Source payment records
|
|||||
| Cerenovus Enterprise Normalized: cerenovus enterprise |
Device | DePuy Synthes Sales Inc. | $186.51 | 3 | 2025 |
Source payment records
|
|||||
| SYNCHRO SELECT Normalized: synchro select |
Device | Stryker Corporation | $155.41 | 2 | 2025 |
Source payment records
|
|||||
| GATEWAY Normalized: gateway |
Device | Stryker Corporation | $142.21 | 1 | 2025 |
Source payment records
|
|||||
| RED 72 Normalized: red 72 |
Device | Penumbra, Inc. | $136.77 | 1 | 2025 |
Source payment records
|
|||||
| SOFIA 6F-131CM STR Normalized: sofia 6f 131cm str |
Device | MicroVention, Inc. | $107.58 | 2 | 2025 |
Source payment records
|
|||||
| Asahi Neurology Wires Normalized: asahi neurology wires |
Device | ASAHI INTECC USA, INC. | $96.17 | 1 | 2025 |
Source payment records
|
|||||
| SOLITAIRE X Normalized: solitaire x |
Device | Medtronic, Inc. | $73.87 | 1 | 2025 |
Source payment records
|
|||||
| POD Normalized: pod |
Device | Penumbra, Inc. | $62.25 | 1 | 2025 |
Source payment records
|
|||||
| WEB ANEURYSM EMBOLIZATION SYSTEM Normalized: web aneurysm embolization system |
Device | MicroVention, Inc. | $54.52 | 1 | 2025 |
Source payment records
|
|||||
| NEUROFORM ATLAS Normalized: neuroform atlas |
Device | Stryker Corporation | $16.06 | 2 | 2025 |
Source payment records
|
|||||
| TRUFILL Normalized: trufill |
Device | DePuy Synthes Sales Inc. | $15.48 | 2 | 2025 |
Source payment records
|
|||||
| AXS INFINITY LS Normalized: axs infinity ls |
Device | Stryker Corporation | $13.95 | 2 | 2025 |
Source payment records
|
|||||
| NEUROSCOUT Normalized: neuroscout |
Device | DePuy Synthes Sales Inc. | $7.75 | 1 | 2025 |
Source payment records
|
|||||
| WINGSPAN Normalized: wingspan |
Device | Stryker Corporation | $6.92 | 1 | 2025 |
Source payment records
|
|||||
| N/A Normalized: n a |
Device | Medical Device Business Services, Inc. | $5.81 | 1 | 2025 |
Source payment records
|
|||||
| LINQ II Normalized: linq ii |
Device | Medtronic, Inc. | $5.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $192,753.53 · 199 records | Medtronic, Inc. | ASAHI Neurovascular Guide Wire, AXIUM PRIMETM, AXS INFINITY LS, Asahi Neurology Wires, BROADWAY 8, Ballast 088 Long Sheath, CEREBASE, CEREPAK UNIFORM, CORE, Carrier Delivery Catheter, Cerenovus Enterprise, EMBOGUARD, EMBOTRAP, GATEWAY, GLIDEWIRE, LINQ II, MO.MA ULTRA, N/A, NA, NEUROFORM ATLAS, NEUROSCOUT, ONYX 18, Optima Coil System, PIPELINE, POD, Penumbra System, Prestige Coil System, RED 72, Raptor Aspiration Catheter, SOFIA 6F-131CM STR, SOLITAIRE X, SURPASS EVOLVE, SYNCHRO SELECT, Stellar Guide Catheter, TARGET, TREVO, TRUFILL, WEB ANEURYSM EMBOLIZATION SYSTEM, WINGSPAN, ZOOM 88-T LARGE DISTAL PLATFORM, ZOOM REPERFUSION CATHETER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error